Table III.

Survival outcomes of epithelioid malignant pleural mesothelioma patients in multivariate analysis models

Parameter	HR (95% CI)*	P-value	HR (95% CI)**	P-value
Stage:
I–II	Ref	0.051	Ref	0.144
III–IV	2.93 (0.99–8.61)		2.30 (0.75–7.05)
KPS:
≥ 80	Ref	0.362	Ref	0.043
< 80	1.98 (0.46–8.56)		5.17 (1.06–25.30)
MDK:
Low	Ref	0.081	Ref	0.014
High	2.65 (0.89–7.96)		4.47 (1.35–14.78)
SDC1:
High	Ref	0.058	Ref	0.074
Low	2.92 (0.97–8.83)		3.09 (0.90–10.63)
HAS2:
High	Ref	0.023	Ref	0.014
Low	2.53 (1.14–5.64)		2.90 (1.24–6.80)
FBLN3:
Low	Ref	0.133	Ref	0.029
High	3.12 (0.71–13.76)		5.93 (1.20–29.22)
SESN1:
High	Ref	0.019	Ref	0.045
Low	4.11 (1.26–13.39)		3.74 (1.03–13.61)
LAMA4:
High	Ref	0.214
Low	0.64 (0.32–1.27)

^*Stage- and KPS-adjusted hazard ratios.

^**Multivariate hazard ratios.